Ibudilast for treating neuropathic pain and associated syndromes

Details for Australian Patent Application No. 2005314133 (hide)

Owner MediciNova, Inc.

Inventors Johnson, Kirk W.; Shumilla, Jennifer; Sulzbaugh, Lance

Agent FB Rice

Pub. Number AU-B-2005314133

PCT Pub. Number WO2006/063048

Priority 60/716,333 12.09.05 US; 60/665,276 25.03.05 US; 60/634,248 06.12.04 US

Filing date 6 December 2005

Wipo publication date 15 June 2006

Acceptance publication date 8 March 2012

International Classifications

A61K 31/437 (2006.01)

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

7 June 2007 PCT application entered the National Phase

  PCT publication WO2006/063048 Priority application(s): WO2006/063048

21 April 2011 Assignment before Grant

  Avigen, Inc. The application has been assigned to MediciNova, Inc. 2006

8 March 2012 Application Accepted

  Published as AU-B-2005314133

29 March 2012 Application for Amendment

  The nature of the amendment is: Amend the name of the inventor to read Johnson, Kirk W.; Shumilla, Jennifer; Sultzbauch, Lance. Address for service in Australia - FB Rice Level 23 200 Queen Street Melbourne VIC 3000 2006

19 July 2012 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to read Johnson, Kirk W.; Sultzbauch, Lance and Shumilla, Jennifer 2006

26 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005314134-Multilayer wire-grid polarizer

2005314127-Selecting patients for therapy with a HER inhibitor